Investigating the role of specific proteins in pulmonary hypertension linked to systemic sclerosis.
Official title: Sine Oculis Homeobox Homolog 1 and clusterin in Pulmonary Hypertension associated with Systemic Sclerosis
Funded at University of Texas Hlth Sci Ctr Houston · NIH-11142212 · Data updated 2026-11-12
This study is looking at how certain proteins might play a role in causing pulmonary hypertension in African American women with systemic sclerosis, with the goal of finding new ways to help treat this serious condition.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | June 16, 2025 |
| Project end | June 15, 2026 |
| Funding year | 2025 |
| Award (this year) | $156,000 |
| NIH project number | 1R03TR005085-01A1 |
| Project ID | NIH-11142212 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African American women diagnosed with systemic sclerosis who are experiencing pulmonary hypertension.
✕Less likely to help
Patients without systemic sclerosis or those who do not have pulmonary hypertension may not benefit from this research.
What this research studies
This research focuses on understanding how the Sine Oculis Homeobox Homolog 1 (SIX1) and clusterin proteins contribute to pulmonary hypertension (PH) in patients with systemic sclerosis (SSc), particularly among African American women. The study aims to explore the mechanisms of vascular remodeling and cell proliferation that lead to PH, a serious condition that can result in the need for lung transplantation. By analyzing tissue samples and cellular responses, the researchers hope to identify new therapeutic targets that could improve treatment outcomes for affected patients.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve the management of pulmonary hypertension in patients with systemic sclerosis.
How similar studies have gone: Preliminary results from similar research have shown promise in understanding the role of SIX1 in vascular remodeling, indicating potential for success in this area.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Karmouty-Quintana, Harry — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Karmouty-Quintana, Harry
Related research
Other NIH-funded projects on the same topics.
-
Detecting early right-heart changes and future lung high blood pressure in systemic sclerosis
This project uses advanced heart ultrasound and machine learning to spot early right-heart changes that may predict pulmonary hypertension in people with systemic sclerosis.
-
Detecting heart problems early in patients with systemic sclerosis
This study is looking for better ways to spot pulmonary arterial hypertension (PAH) early in people with systemic sclerosis (SSc) by using new imaging techniques and smart computer tools, so that doctors can help patients sooner and improve their health.
-
Understanding how CD4 T cells fuel schistosomiasis-related lung disease
A study explores how specific immune cells and inflammatory signals in schistosomiasis may contribute to pulmonary hypertension in people affected by the disease.
-
CD4 T Cells, Schistosoma, and Pulmonary Hypertension: Understanding How Immune Cells Drive Disease
A human-health focused study uses a mouse model and human samples to explore how immune cells and inflammation may contribute to a lung blood vessel disease linked to schistosomiasis.
-
CD4 T Cells and Schistosoma-Related Pulmonary Hypertension
A study to understand how specific immune cells behave in a lung complication caused by schistosomiasis, with the goal of finding targets to prevent or treat it.
-
Clinical CT Imaging to identify and subtype pulmonary hypertension in COPD
A new CT imaging approach aims to help doctors detect and classify pulmonary hypertension in people with COPD.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.